CME/CE: Botulinum Toxin May Prevent Afib Folllowing Bypass
By: Alere Staff
American Heart Association
October 21, 2015 – October 21, 2017
Physicians: 0.25 AMA PRA Category 1 Credit(s) ™
Injections of botulinum toxin into the fat surrounding the heart following coronary bypass significantly reduced the incidence of atrial fibrillation immediately after surgery and a year later. The results from the small study show that treatment with botulinum toxin can effectively suppress Afib incidence long-term following surgery, but the findings will need to be confirmed in larger trials.